Literature DB >> 35113250

Recharacterization of superior limbic keratoconjunctivitis via a subdividing grading method in 236 Chinese patients.

Chao Cheng1, Minyi Zhu1,2, Tianlan Lin1, Ziyan Chen1, Weiting Zeng1, Kunke Li1, Ran Xue1, Fang Duan1, Kaili Wu3.   

Abstract

PURPOSE: Superior limbic keratoconjunctivitis (SLK) is an uncommon and often overlooked chronic ocular surface disease. This retrospective consecutive case series study on Chinese patients aimed to characterize the features of this disease, including those undescribed in previous literature.
METHODS: Two hundred thirty-six patients diagnosed with SLK were enrolled into this consecutive case study from 2016 to 2019. The demographics, symptoms, Ocular Surface Disease Index, and ocular signs were collected and analyzed. A scoring system (SLK scale index, SSI) that integrated five major sign scores was applied to evaluate SLK severity.
RESULTS: Of the 236 SLK patients, dryness was the most common complaint (59.3%). Of 459 SLK eyes, superior limbus/conjunctival staining (SCS) was present in 98% eyes, followed by the superior tarsal conjunctival alterations (85.2%) and superior bulbar conjunctiva hyperemia (80.8%). Approximately 63% of eyes were accompanied by corneal staining. Superior bulbar conjunctivochalasis was a relatively rare sign (41.6%). Among the five major signs, only the prevalence of SCS gradually increased with its severity. In addition, fluorescein staining at the inferior limbus and adjacent conjunctiva (ICS) was found positive in 163 eyes of 84 patients (36%) who had significantly higher SSI than those without ICS (p = 0.013).
CONCLUSIONS: We found that SCS is the most common out of the 5 typical signs of SLK. ICS, a new sign, occurred in one-third of patients. SCS, a simple marker of SLK, as well as SSI, an integrated evaluation system, had the advantage of evaluating the severity and objectively characterizing SLK in clinical practice.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Clinical features; Conjunctival staining; SLK scale index; Superior conjunctival hyperemia; Superior limbic keratoconjunctivitis

Mesh:

Year:  2022        PMID: 35113250     DOI: 10.1007/s00417-022-05575-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  New surgical treatment for superior limbic keratoconjunctivitis and its association with conjunctivochalasis.

Authors:  Norihiko Yokoi; Aoi Komuro; Kunio Maruyama; Masakatsu Tsuzuki; Seiya Miyajima; Shigeru Kinoshita
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

2.  Ocular surface disease index for the diagnosis of dry eye syndrome.

Authors:  Fatih Ozcura; Sayime Aydin; Mehmet Rami Helvaci
Journal:  Ocul Immunol Inflamm       Date:  2007 Sep-Oct       Impact factor: 3.070

3.  New surgical approach for superior conjunctivochalasis.

Authors:  Ahmad Kheirkhah; Victoria Casas; Salomon Esquenazi; Gabriela Blanco; Wei Li; V-K Raju; Scheffer C G Tseng
Journal:  Cornea       Date:  2007-07       Impact factor: 2.651

4.  Conjunctival resection combined with tenon layer excision and the involvement of mast cells in superior limbic keratoconjunctivitis.

Authors:  Yi-Chen Sun; Cheng-Hsiang Hsiao; Wei-Li Chen; I-Jong Wang; Yu-Chih Hou; Fung-Rong Hu
Journal:  Am J Ophthalmol       Date:  2008-01-16       Impact factor: 5.258

5.  Tear cytokine profiling in patients with superior limbic keratoconjunctivitis who underwent medical treatment or in conjunction with surgical management.

Authors:  Yi-Chen Sun; Yi-Hua Tang; Hau-Min Liou; Wei-Li Chen; Fung-Rong Hu
Journal:  Br J Ophthalmol       Date:  2019-03-29       Impact factor: 4.638

6.  Observations on conjunctival neoplasms masquerading as chronic conjunctivitis or keratitis.

Authors:  P Thygeson
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1969 Sep-Oct

7.  Superior Limbic Keratoconjunctivitis-like Inflammation in Patients with Chronic Graft-Versus-Host Disease.

Authors:  Kavitha R Sivaraman; Renu V Jivrajka; Ketki Soin; Charles S Bouchard; Asadolah Movahedan; Ellen Shorter; Sandeep Jain; Deborah S Jacobs; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-05-12       Impact factor: 5.033

8.  Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.

Authors:  Alejandro Rodriguez-Garcia; Yolanda Macias-Rodriguez; Jose M Gonzalez-Gonzalez
Journal:  Int Ophthalmol       Date:  2017-06-10       Impact factor: 2.031

9.  Clinical Severity Classification using Automated Conjunctival Hyperemia Analysis Software in Patients with Superior Limbic Keratoconjunctivitis.

Authors:  Junki Kurita; Jun Shoji; Noriko Inada; Tsuyoshi Yoneda; Tamaki Sumi; Masahiko Kobayashi; Yasuhiro Hoshikawa; Atsuki Fukushima; Satoru Yamagami
Journal:  Curr Eye Res       Date:  2018-01-16       Impact factor: 2.424

Review 10.  Superior limbic keratoconjunctivitis: a comprehensive review.

Authors:  Sejal Lahoti; Menachem Weiss; Daniel A Johnson; Ahmad Kheirkhah
Journal:  Surv Ophthalmol       Date:  2021-05-30       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.